Increasing implants at the current rate would suit me at this...

Increasing implants at the current rate would suit me at this stage. Thing is, when the DT trial gets underway it will increase even more.

I liked what Dr Esmore said in relation to patient sucsess. Around 85% survival rate and expected to get even better with a better understanding of selecting appropriate patients. US BTT trial will certainly be passed with flying colours at that rate.

The sales info is what is holding this stock back IMO. A more clearer picture with sales will provide the spark this stock needs.